Previous studies reported that serum IGFBP2 levels were significantly elevated in patients with malignancies [12], rheumatic diseases [13–15], and kidney diseases [16] and that serum IGFBP2 levels were closely related with disease severity. Here, IGFBP2 is linked to kidney disorder.